Literature DB >> 2178279

Hepatitis C virus infection in intravenous drug users: prevalence and risk factors.

E Girardi1, M Zaccarelli, G Tossini, V Puro, P Narciso, G Visco.   

Abstract

We investigated the relation of drug use and sexual behaviour to hepatitis C virus (HCV) infection among 80 intravenous drug users (IVDU) attending a methadone treatment program in Rome. Antibodies to HCV (anti-HCV) were found in 54/80 of IVDU (67.5%). Presence of anti-HCV was associated with duration of intravenous drug use and frequency of needle sharing (p less than 0.003 and p = 0.02, respectively, by chi-square for trend). No association was found between sexual behaviour and anti-HCV prevalence.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2178279     DOI： 10.3109/00365549009027133

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  11 in total

1.  Syringe Sharing Among a Prospective Cohort of Street-Involved Youth: Implications for Needle Distribution Programs.

Authors:  Nikki Bozinoff; Evan Wood; Huiru Dong; Lindsey Richardson; Thomas Kerr; Kora DeBeck
Journal:  AIDS Behav       Date:  2017-09

2.  Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan.

Authors:  C J Chang; C H Lin; C T Lee; S J Chang; Y C Ko; H W Liu
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

Review 3.  Sexual transmission of hepatitis C virus infection.

Authors:  G Rooney; R J Gilson
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

4.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

Authors:  I van Beek; R Dwyer; G J Dore; K Luo; J M Kaldor
Journal:  BMJ       Date:  1998-08-15

5.  Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.

Authors:  D S Holsen; S Harthug; H Myrmel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

6.  Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.

Authors:  Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

7.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

8.  A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.

Authors:  M A Balogun; M E Ramsay; J V Parry; L Donovan; N J Andrews; J A Newham; C McGarrigle; K A Harris; C G Teo
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

9.  Hepatitis C Virus infections trends in Italy, 1996-2006.

Authors:  Giuseppe La Torre; Maria Rosaria Gualano; Leda Semyonov; Nicola Nicolotti; Walter Ricciardi; Antonio Boccia
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

10.  Prevalence of Hepatitis C virus antibody in patients with sexually transmitted diseases attending a Harrisburg, PA, STD clinic.

Authors:  R L Sautter; S Jones; D I Weber; W D Lebar; D F Heitjan; M M Kopreski; F D Curcio
Journal:  Infect Dis Obstet Gynecol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.